跳至主要内容
临床试验/NCT00191581
NCT00191581已完成3 期

Comparison of 2-Hour Postprandial Blood Glucose Excursion in Response to a Standard Test Meal in Insulin-Requiring Diabetic Patients Treated Twice Daily With Either Insulin Lispro Mix 50/50 or Human Insulin Mix 50/50

Eli Lilly and Company2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2005年3月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
120
试验地点
2
主要终点
The primary objective of this study is to compare the 2-hour PPBG excursion following a standard test meal in IDDM patients treated BID with human insulin mix 50/50, vs the 2-hour PPBG excursion in patients treated BID with insulin lispro mix 50/50

研究概览

简要总结

The primary objective of this study is to compare the 2-hour PPBG excursion following a standard test meal in insulin-requiring diabetic patients treated twice daily with human insulin mix 50/50, versus the 2-hour PPBG excursion in patients treated twice daily with insulin lispro mix 50/50.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women who have had either type 1 or type 2 diabetes (World Health Organization[WHO]classification)for at least 2 months and are between the ages of 18 and 70 (inclusive) at the signing of the informed consent.
  • Have been treated with commercially available human insulin mix 50/50 or human insulin mix 30/70 twice daily as the only pharmacological treatment for their diabetes for at least 2 months prior to entering the study.
  • Have an HbA1c between 1.1 and 1.7 times the upper limit of the normal reference rang(inclusive) as determined by a local laboratory within 2 weeks prior to or at Visit
  • Have achieved compliance with their diets and insulin therapies as determined by the investigators and perform regular blood glucose monitoring.
  • Have given informed consent to participate in this study in accordance with local regulations.

排除标准

  • {1] Have used oral antidiabetic agents, including biguanides, sulfonylureas, glucosidase inhibitors, and insulin-sensitivity enhancers within 30 days prior to entry into the study.
  • [2] Receive a total daily dose of insulin >2 units/kg.
  • [3] Have had more than two episodes of severe hypoglycemia (defined as requiring assistance of another person due to disabling hypoglycemia) within 6 months prior to entry into the study.
  • [4] Have a body mass index >35 kg/m
  • [5] Have serum creatinine > the upper limit of normal (ULN), as determined by a local laboratory.

结局指标

主要结局

The primary objective of this study is to compare the 2-hour PPBG excursion following a standard test meal in IDDM patients treated BID with human insulin mix 50/50, vs the 2-hour PPBG excursion in patients treated BID with insulin lispro mix 50/50

次要结局

  • Effects on HbA1c values obtained at the end of each treatment period;
  • Assess hemoglobin A1c (HbA1c) values at baseline and after treatment with insulin lispro mix 50/50.
  • Effects on fasting blood glucose values obtained throughout the study;
  • The secondary objectives of the study are:
  • To compare human insulin mix 50/50 with insulin lispro mix 50/50 with regard to
  • Assess HbA1c values at baseline and after treatment with human insulin mix 50/50.

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验